Speaker illustration

Doctor Hirotoshi Watanabe

Hirakata Kohsai Hospital, Hirakata (Japan)

Member of:

European Society of Cardiology

STOPDAPT-2 ACS: one-month dual antiplatelet therapy followed by clopidogrel monotherapy in acute coronary syndrome

Event: ESC Congress 2021 - The Digital Experience

Topic: Adjunctive Pharmacotherapy

Session: Hot Line - STOPDAPT-2 ACS


Post-discharge myocardial infarction after percutaneous coronary intervention: incidence, risk factors, size distribution and its prognostic significance

Event: ESC Congress 2017

Topic: PCI: long-term outcome

Session: PCI - Long-term outcome


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb